Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ian Schofield

Edinburgh, U.K
Ian Schofield has been writing on issues affecting the pharmaceutical and biotech industry since the mid-1980s, specialising in EU and global policy and regulatory affairs.  As well as writing, editing and commissioning articles for Pharma Intelligence, Ian works for the Ask the Analyst service, providing tailor-made answers to questions posed directly by clients. He has a degree in modern languages from the University of Bath. Outside the realm of work, Ian plays guitar in a traditional music group and also enjoys a touch of cycling and gardening. He lives by the seaside about three miles from the centre of Edinburgh.
Advertisement
Set Alert for Articles By Ian Schofield

Latest From Ian Schofield

Italy Unveils New Payment Model For Novartis’s CAR-T Kymriah

The Italian authorities have agreed a new kind of reimbursement model for Novartis's CAR-T therapy Kymriah that involves payment in instalments depending on the patient’s response to treatment.

Italy Reimbursement

NHS England Tackles Barriers To Use Of Cannabis-Based Medicines in UK

A review of barriers to the prescribing of cannabis-based medicines for children with epilepsy in England suggests that much needs to be done to generate the necessary evidence to assuage prescribers’ concerns. 

United Kingdom Neurology

UK Takes More Action To Fly In No-Deal Brexit Drug Supplies

In the latest move in its no-deal Brexit preparations, the UK is offering a contract for suppliers to provide an “uninterrupted supply of medicines and medical products,” including temperature controlled and time-sensitive medicines.
United Kingdom Brexit

UK Seeks Cargo Planes To Fly In Post-Brexit Medical Device And Drug Supplies

As preparations for a no-deal Brexit intensify, the UK government has published a tender asking for freight operators to transport medical devices, medicine and other essential products to the UK, whether by air, land or sea, to “preserve human welfare.”

United Kingdom Brexit

Romanian Agency Reorganizes To Boost Performance & Face Brexit Challenge

The Romanian medicines agency is to be reorganized to improve the way it works and allow it to take on more work as a result of Brexit. One consequence is that industry fees may have to rise to pay for this work as well as a sharp rise in staff numbers.
Romania Regulation

UK Seeks Cargo Planes To Fly In Post-Brexit Medicines Supplies

As preparations for a no-deal Brexit intensify, the UK government has published a tender asking for freight operators to transport medicines and other essential products to the UK, whether by air, land or sea, to “preserve human welfare”.

United Kingdom Brexit
See All
Advertisement
UsernamePublicRestriction

Register